Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2012 1
2013 2
2014 1
2015 1
2016 9
2017 9
2018 7
2019 7
2020 8
2021 15
2022 13
2023 8
2024 6
2025 12

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

85 results

Results by year

Filters applied: . Clear all
Page 1
Rituximab Versus Conventional Therapy for Remission Induction in Eosinophilic Granulomatosis With Polyangiitis : A Randomized Controlled Trial.
Terrier B, Pugnet G, de Moreuil C, Bonnotte B, Benhamou Y, Chauveau D, Besse MC, Duffau P, Limal N, Néel A, Urbanski G, Jourde-Chiche N, Martin-Silva N, Campagne J, Mekinian A, Schleinitz N, Ackermann F, Fauchais AL, Froissart A, Le Gallou T, Uzunhan Y, Viallard JF, Bérezné A, Chiche L, Taillé C, Direz G, Durel CA, Godmer P, Trad S, Lambert M, de Menthon M, Quéméneur T, Cadranel J, Charles P, Dossier A, Jilet L, Guillevin L, Abdoul H, Puéchal X; French Vasculitis Study Group. Terrier B, et al. Among authors: dossier a. Ann Intern Med. 2025 Sep;178(9):1249-1257. doi: 10.7326/ANNALS-24-03947. Epub 2025 Jul 29. Ann Intern Med. 2025. PMID: 40720835 Clinical Trial.
Hypereosinophilia and Hypereosinophilic Syndromes: First Findings From a Nationwide Multicenter Cohort.
Lefèvre G, Bleuse S, Puyade M, Moulis G, Néel A, Abisror N, Baudet A, Bonnotte B, Dion J, Dossier A, Grall M, Lifermann F, Limal N, Lioger B, Machelart I, Mohr C, Outh R, Queyrel-Moranne V, Slama B, Tréfond L, Abou Chahla W, Ackerman F, Belfeki N, Berezne A, Blade JS, Bouderbala MA, Chebrek S, Cottin V, De Almeida S, De Masson A, Dezoteux F, Goulenok T, Jachiet V, Jouvray M, Latu I, Ledoult E, Leurs A, Lugosi M, Martin M, Melboucy-Belkhir S, Morati-Hafsaoui C, Quemeneur T, Rohmer J, Roy-Peaud F, Sanges S, Schleinitz N, Staumont-Salle D, Taillé C, Terriou L, Tieulie N, Koenga JDE, Schwarb L, Panel K, Kahn JE, Groh M; COHESion study group. Lefèvre G, et al. Among authors: dossier a. Allergy. 2025 Apr;80(4):1100-1110. doi: 10.1111/all.16463. Epub 2025 Jan 5. Allergy. 2025. PMID: 39757773
Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials.
Siempos II, Kalil AC, Belhadi D, Veiga VC, Cavalcanti AB, Branch-Elliman W, Papoutsi E, Gkirgkiris K, Xixi NA, Kotanidou A, Hermine O, Porcher R, Mariette X; CORIMUNO-19 Collaborative Group; DisCoVeRy Study Group; ACTT-2 Study Group; ACTT-3 Study Group. Siempos II, et al. EClinicalMedicine. 2024 Feb 9;69:102472. doi: 10.1016/j.eclinm.2024.102472. eCollection 2024 Mar. EClinicalMedicine. 2024. PMID: 38361992 Free PMC article.
Efficacy and safety of targeted therapies in VEXAS syndrome: retrospective study from the FRENVEX.
Hadjadj J, Nguyen Y, Mouloudj D, Bourguiba R, Heiblig M, Aloui H, McAvoy C, Lacombe V, Ardois S, Campochiaro C, Maria A, Coustal C, Comont T, Lazaro E, Lifermann F, Le Guenno G, Lobbes H, Grobost V, Outh R, Campagne J, Dor-Etienne A, Garnier A, Jamilloux Y, Dossier A, Samson M, Audia S, Nicolas B, Mathian A, de Maleprade B, De Sainte-Marie B, Faucher B, Bouaziz JD, Broner J, Dumain C, Antoine C, Carpentier B, Castel B, Lartigau-Roussin C, Crickx E, Volle G, Fayard D, Decker P, Moulinet T, Dumont A, Nguyen A, Aouba A, Martellosio JP, Levavasseur M, Puigrenier S, Antoine P, Giraud JT, Hermine O, Lacout C, Martis N, Karam JD, Chasset F, Arnaud L, Marianetti P, Deligny C, Chazal T, Woaye-Hune P, Roux-Sauvat M, Meyer A, Sujobert P, Hirsch P, Abisror N, Fenaux P, Kosmider O, Jachiet V, Fain O, Terrier B, Mekinian A, Georgin-Lavialle S; FRENVEX. Hadjadj J, et al. Among authors: dossier a. Ann Rheum Dis. 2024 Sep 30;83(10):1358-1367. doi: 10.1136/ard-2024-225640. Ann Rheum Dis. 2024. PMID: 38777378
Association between large vessel vasculitis and inflammatory bowel disease: a case-control study.
Maillet F, Nguyen Y, Espitia O, Perard L, Salvarani C, Rivière E, Ndiaye D, Durel CA, Guilpain P, Mouthon L, Kernder A, Loricera J, Cohen P, Melki I, de Moreuil C, Limal N, Mékinian A, Costedoat-Chalumeau N, Morel N, Boutemy J, Raffray L, Allain JS, Devauchelle V, Kone-Paut I, Fabre M, Durel M, Dossier A, Abad S, Visentini M, Bigot A, Yildiz H, Fain O, Samson M, Gondran G, Abitbol V, Terrier B. Maillet F, et al. Among authors: dossier a. Rheumatology (Oxford). 2025 Jun 1;64(6):3724-3732. doi: 10.1093/rheumatology/keaf030. Rheumatology (Oxford). 2025. PMID: 39898825
Nonischemic Cardiac Manifestations in VEXAS Syndrome.
Robert M, Mathian A, Lacombe V, Lobbes H, Adélaïde L, Le Besnerais M, Dacher JN, Terrier B, Mékinian A, Bourguiba R, Georgin-Lavialle S; FRENVEX Group. Robert M, et al. JAMA Netw Open. 2024 Dec 2;7(12):e2450251. doi: 10.1001/jamanetworkopen.2024.50251. JAMA Netw Open. 2024. PMID: 39666342 Free PMC article.
Prognostic factors for patients with cancer-associated dermatomyositis: a retrospective, multicentre cohort study of 73 patients.
Teboul A, Allenbach Y, Tubach F, Belin L, Cassius C, Demortier J, Dossier A, Faucon C, Kasser C, Mekinian A, Monseau G, Fouchard M, Chambrelan E, Viguier M, Kluger N, Mahévas T, Bergeret B, Bachmeyer C, Lenormand C, Hotz C, Diaz E, Cordel N, Benveniste O, Bessis D, Bouaziz JD, Chasset F. Teboul A, et al. Among authors: dossier a. Rheumatology (Oxford). 2025 May 1;64(5):2970-2978. doi: 10.1093/rheumatology/keae629. Rheumatology (Oxford). 2025. PMID: 39589730
Intravenous immunoglobulin as a rescue therapy for severe adult autoimmune hemolytic anemia: Results from a French multicenter observational study.
Michel M, Saïr M, Rivière E, Moulis G, Comont T, Costedoat-Chalumeau N, Pouchelon C, Boutboul D, Benyamine A, Bert A, Jeandel PY, Hamrouni S, Belfeki N, Lobbes H, Dossier A, Gobert D, Mahevas M, Godeau B, Gallien Y, Ebbo M. Michel M, et al. Among authors: dossier a. Am J Hematol. 2024 Aug;99(8):1616-1619. doi: 10.1002/ajh.27361. Epub 2024 May 14. Am J Hematol. 2024. PMID: 38742870 Free article. No abstract available.
85 results